Targeting GIP and GLP-1 to Individualize Treatment in Patients With T2DM and Obesity Published 2022-05-06 Download video MP4 360p Recommendations 58:16 The Increasing Importance of GLP-1–Based Therapies for Personalized Obesity Management 16:45 Interpreting the Data with Tirzepatide 1:15:36 Salt Sugar Fat - Michael Moss 1:10:53 Dr Ben Bikman - The Truth about GLP 1, Ozempic and Insulin resistance - Inspiring better health Ep.4 1:02:44 Exploring the Science and Practice of GLP-1 Receptor Agonists 59:10 Henrietta Lacks and HeLa Cells: Impact on Biological Research and Informed Consent 47:52 What is GLP-1, What Does It Do, and Where Does It Come From? with Dr. Ben Bikman 38:39 Is Ozempic (Semaglutide) Right For Me? 1:07:25 Navigating GLP-1 agonists | DoM Grand Rounds | 17 January 2024 1:02:26 Management of Diabetes in 2023: Updates and Future Directions 1:02:08 How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments 12:33 Dr Jason Fung’s BRUTALLY Honest Opinion On OZEMPIC 52:30 Next Generation Refractive IOLs 13:54 Using GLP1 receptor agonists to treat cardiac patients with diabetes 2:06:19 Emily Hodges, Cold Spring Harbor Laboratory 08:49 Mechanisms of Action of GLP-1 Agonists in T2D 22:43 Highly Successful Weight Loss Drug Semaglutide Explained Similar videos 32:30 Reducing Cardiometabolic Risks and Achieving Glycemic Targets With GLP-1 RAs 50:39 Is type 2 diabetes reversible? 9 November 2021 58:55 Early GLP-1 RA Initiation to Reduce Risks and Improve Long-Term Outcomes in T2DM 07:39 Differences Between Semaglutide and Tirzepatide 08:24 Tirzepatide's Unique Mechanism of Action - GIP/GLP-1 Dual Agonist 01:49 Once-Weekly Tirzepatide for Obesity | NEJM 09:31 Prescribing GLP-1 Receptor Agonists for Weight Loss 02:04 How glucagon-like peptide 1 receptor agonists work to improve diabetes control. 37:07 New Goals and Therapeutic Options for Type 2 Diabetes Mellitus 09:56 The Story of GLP-1 - Episode 1: "A diabetes doctor’s dream" 05:44 Mechanism of Action for GLP 1 RAs: "The How" More results